Guinea-Bissau

in page functions
Total population (2012)1,579,632
Birth cohort (2012)59,436
Surviving Infants (surviving to 1 year per year, 2012)52,851
Infant mortality rate (deaths < 1 year per 1000 births, 2012)110.80/1000
Child mortality rate (deaths < 5 years per 1000 births, 2012)182.75/1000
World Bank Index, IDA (2012)2.70
Gross Nation Income (per capita US$, 2010)590
Co-financing status (2012)Low-income
No. of districts/territories (2009)11

Contact GAVI

For more info, contact GAVI country representative officer or email here

GAVI support for Guinea-Bissau

Type of support

Approvals

2001-2016 (US$)
(31 Dec 2011)

Commitments

2001-2016 (US$)
(31 Dec 2011)

Disbursements

2001-2012 (US$)
(31 Dec 2011)

% Disbursed

(31 Dec 2011)
200320042005200620072008200920102011201220132014
Health System Strengthening (HSS)$601,500$1,428,000$338,50056%
Immunisation Services Support (ISS)$500,360$630,860$500,360100%
Injection Safety Support (INS)$115,787$115,787$115,787100%
Penta (NVS)$2,494,954$3,380,454$2,401,57496%
Vaccine Introduction Grant$200,000$200,000$200,000100%
Yellow Fever (NVS)$220,916$324,416$221,920100%
Total$4,133,517$6,079,517$3,778,141

Red line on table indicates duration of support based on commitments.
Commitments: Multi-year programme budgets endorsed in principle by the GAVI Board. These become financial commitments upon approval each year for the following calendar year.
Approvals: Total Approved for funding (IRC Reviewed)

Download data for commitments & disbursements in XLS format

Guinea-Bissau DTP3 / immunisation coverage

DTP3 - WHO/UNICEF estimates (2010)76%
DTP3 - Official country estimates (2010)86%
M:F sex ratio at birth (2012)1.03%
Household survey: DTP3 coverage for male (2006)62.50%
Household survey: DTP3 coverage for female (2006)61.70%
Household survey: Last DTP3 survey (2006)62%
% districts achieving > 80% DTP3 coverage (2010)409%
% districts achieving < 50% DTP3 coverage (2010)0%
MCV WHO/UNICEF estimates (2010)61%
Polio WHO/UNICEF estimates (2010)73%

Breakdown of support

CSO, HSS & ISS supportVaccine support
31% 69%
$1,154,647 $2,623,494

Data refers to disbursed values, date as per above chart

Move mouse over graph for details

close icon

modal window here